Fuse Vectors

Fuse Vectors develops a modular cell-free technology platform for the manufacturing of AAV viral vectors used in gene therapy. The company utilizes a four-hour reaction process to replace multi-week cell cultures, aiming to increase full particle purity and reduce production costs. Their target market includes biotechnology and pharmaceutical entities seeking scalable manufacturing solutions from discovery to clinical stages.